Cost-Effectiveness of Patient Navigation to Increase Adherence With Screening Colonoscopy Among Minority Individuals

被引:34
|
作者
Ladabaum, Uri [1 ,2 ]
Mannalithara, Ajitha [1 ,2 ]
Jandorf, Lina [3 ]
Itzkowitz, Steven H. [4 ]
机构
[1] Stanford Univ, Sch Med, Div Gastroenterol Hepatol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[3] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Div Canc Prevent & Control, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, Dept Med, New York, NY 10029 USA
关键词
colorectal cancer; colorectal neoplasia; screening; adherence; disparities; FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; SERVICES TASK-FORCE; COLORECTAL-CANCER; CLINICAL-TRIAL; STRATEGIES; RECOMMENDATIONS; SIGMOIDOSCOPY; SURVEILLANCE; POLYPECTOMY;
D O I
10.1002/cncr.29162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDColorectal cancer (CRC) screening is underused by minority populations, and patient navigation increases adherence with screening colonoscopy. In this study, the authors estimated the cost-effectiveness of navigation for screening colonoscopy from the perspective of a payer seeking to improve population health. METHODSA validated model of CRC screening was informed with inputs from navigation studies in New York City (population: 43% African American, 49% Hispanic, 4% white, 4% other; base-case screening: 40% without navigation, 65% with navigation; navigation costs: $29 per colonoscopy completer, $21 per noncompleter, $3 per non-navigated individual). Two analyses compared: 1) navigation versus no navigation for 1-time screening colonoscopy in unscreened individuals aged 50 years; and 2) programs of colonoscopy with versus without navigation versus fecal occult blood testing (FOBT) or fecal immunochemical testing (FIT) for individuals ages 50 to 80 years. RESULTSIn the base case: 1) 1-time navigation gained quality-adjusted life-years (QALYs) and decreased costs; 2) longitudinal navigation cost $9800 per QALY gained versus no navigation, and, assuming comparable uptake rates, it cost $118,700 per QALY gained versus FOBT but was less effective and more costly than FIT. The results were most dependent on screening participation rates and navigation costs: 1) assuming a 5% increase in screening uptake with navigation, and a navigation cost of $150 per completer, 1-time navigation cost $26,400 per QALY gained; and 2) longitudinal navigation with 75% colonoscopy uptake cost <$25,000 per QALY gained versus FIT when FIT uptake was <50%. Probabilistic sensitivity analyses did not alter the conclusions. CONCLUSIONSNavigation for screening colonoscopy appears to be cost-effective, and 1-time navigation may be cost-saving. In emerging health care models that reward outcomes, payers should consider covering the costs of navigation for screening colonoscopy. Cancer 2015;121:1088-1097. (c) 2014 American Cancer Society. Navigation increases uptake of screening colonoscopy among minority individuals. The results from this study suggest that navigation in a longitudinal screening colonoscopy program is likely to be cost effective, and that 1-time navigation in previously unscreened indivaduals may be cost saving.
引用
收藏
页码:1088 / 1097
页数:10
相关论文
共 50 条
  • [31] Timeliness of Surveillance Colonoscopy in Underserved Populations: Association with Patient Navigation for Initial Screening Colonoscopy
    Percac-Lima, Sanja
    Ashburner, Jeffrey M.
    Enogieru, Imarhia
    Ho, J. Janet
    Mitton, Julian
    Richter, James M.
    He, Wei
    Whited, Emma C.
    Atlas, Steven J.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2021, 32 (02) : 712 - 723
  • [32] Repeat Colonoscopy Every 10 Years or Single Colonoscopy for Colorectal Neoplasm Screening in Average-risk Chinese: A Cost-effectiveness Analysis
    Wang, Zhen-Hua
    Gao, Qin-Yan
    Fang, Jing-Yuan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 1761 - 1766
  • [33] Cost-effectiveness of colorectal cancer screening - An overview
    Lansdorp-Vogelaar, Iris
    Knudsen, Amy B.
    Brenner, Hermann
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2010, 24 (04) : 439 - 449
  • [34] Cost-effectiveness of blood-based colorectal cancer screening - a simulation model incorporating real-world longitudinal adherence
    Donderici, Elifnur Yay
    Forbes, Shaun P.
    Zhang, Nicole J.
    Schafer, Gregory
    Raymond, Victoria M.
    Das, Amar K.
    Eagle, Craig
    Talasaz, Amirali
    Grady, William M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025,
  • [35] Cost-effectiveness of "full spectrum endoscopy" colonoscopy for colorectal cancer screening
    Hassan, Cesare
    Gralnek, Ian M.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (05) : 390 - 394
  • [36] Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies
    Sharaf, Ravi N.
    Ladabaum, Uri
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (01) : 120 - 132
  • [37] Impact of a Multifaceted Intervention on Promoting Adherence to Screening Colonoscopy Among Persons in HIV Primary Care: A Pilot Study
    Ferron, Pansy
    Asfour, Shihab S.
    Metsch, Lisa R.
    Antoni, Michael H.
    Rodriguez, Allan E.
    Duncan, Robert
    Findlay, Sheila M.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2015, 8 (04): : 290 - 297
  • [38] The economic impact of a patient navigator program to increase screening colonoscopy
    Elkin, Elena B.
    Shapiro, Ephraim
    Snow, Jacqueline G.
    Zauber, Ann G.
    Krauskopf, Marian S.
    CANCER, 2012, 118 (23) : 5982 - 5988
  • [39] Cost-effectiveness analysis of postpolypectomy colonoscopy surveillance using Japanese data
    Sekiguchi, Masau
    Igarashi, Ataru
    Sakamoto, Taku
    Saito, Yutaka
    Esaki, Minoru
    Matsuda, Takahisa
    DIGESTIVE ENDOSCOPY, 2019, 31 (01) : 40 - 50
  • [40] Validation of Models That Estimate the Cost-Effectiveness of Improving Patient Adherence
    Gandjour, Afschin
    VALUE IN HEALTH, 2013, 16 (08) : 1170 - 1171